In confirmation with previous studies showing MDM alternative activation is essential for efficient erythrophagocytosis and hematoma clearance (Chang et al, 2018, 2020), we observed impaired MDM phagocytosis of erythrocytes in the HSD hemorrhagic brains (Fig 2B). This evidence concerns the gene CHST3 and hematoma.